Vimarsana
Biggest News Aggregation in the World

Page 2 - Bofi Holding News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bofi Holding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bofi Holding Today - Breaking & Trending Today

Summary Notice of Proposed Class Action Settlement Involving BofI Holding, Inc. Common Stock, Call Options and Put Options - Vimarsana News

Summary Notice of Proposed Class Action Settlement Involving BofI Holding, Inc. Common Stock, Call Options and Put Options

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Critical Review: Axos Financial (NASDAQ:AX) and TC Bancshares (NASDAQ:TCBC) - Vimarsana News

Critical Review: Axos Financial (NASDAQ:AX) and TC Bancshares (NASDAQ:TCBC)

Axos Financial (NASDAQ:AX – Get Rating) and TC Bancshares (NASDAQ:TCBC – Get Rating) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership. Analyst Recommendations This is a breakdown of current ratings and […]

Reviewing Territorial Bancorp (NASDAQ:TBNK) & Axos Financial (NASDAQ:AX) - Vimarsana News

Reviewing Territorial Bancorp (NASDAQ:TBNK) & Axos Financial (NASDAQ:AX)

Territorial Bancorp (NASDAQ:TBNK – Get Rating) and Axos Financial (NASDAQ:AX – Get Rating) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, profitability, dividends and risk. Valuation & Earnings This table compares Territorial Bancorp and Axos […]

In Re Nektar Therapeutics: Ninth Circuit Affirms Dismissal Of Securities Class Action Arising From Failure Of Clinical Drug Trial - Securities - Vimarsana News

In Re Nektar Therapeutics: Ninth Circuit Affirms Dismissal Of Securities Class Action Arising From Failure Of Clinical Drug Trial - Securities

On May 19, 2022, a panel of the Ninth Circuit unanimously affirmed the district court's dismissal of a putative securities fraud class action accusing Nektar Therapeutics and several of...

Source: mondaq.com
In re Nektar Therapeutics: Ninth Circuit Affirms Dismissal of Securities Class Action Arising from Failure of Clinical Drug Trial   | Cooley LLP - Vimarsana News

In re Nektar Therapeutics: Ninth Circuit Affirms Dismissal of Securities Class Action Arising from Failure of Clinical Drug Trial   | Cooley LLP

Summary - On May 19, 2022, a panel of the Ninth Circuit unanimously affirmed the district court’s dismissal of a putative securities fraud class action accusing Nektar...